These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 11115618

  • 1. Expression of metalloproteinases and its inhibitor in later stage of rabbit neointima development.
    Wang H, Liu C, Song Y, Gordon D, Alavi MZ, Moore S.
    Int J Mol Med; 2001 Jan; 7(1):105-12. PubMed ID: 11115618
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.
    Kranzhöfer A, Baker AH, George SJ, Newby AC.
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):255-65. PubMed ID: 9974405
    [Abstract] [Full Text] [Related]

  • 4. Expression of membrane-type 1 matrix metalloproteinase in coronary vessels of allotransplanted primate hearts.
    Tsukioka K, Suzuki J, Kawauchi M, Wada Y, Zhang T, Nishio A, Koide N, Endoh M, Takayama K, Takamoto S, Isobe M, Amano J.
    J Heart Lung Transplant; 2000 Dec; 19(12):1193-8. PubMed ID: 11124489
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat.
    Curry TE, Song L, Wheeler SE.
    Biol Reprod; 2001 Sep; 65(3):855-65. PubMed ID: 11514351
    [Abstract] [Full Text] [Related]

  • 7. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle.
    Young KA, Hennebold JD, Stouffer RL.
    Mol Hum Reprod; 2002 Sep; 8(9):833-40. PubMed ID: 12200461
    [Abstract] [Full Text] [Related]

  • 8. The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14.
    Filanti C, Dickson GR, Di Martino D, Ulivi V, Sanguineti C, Romano P, Palermo C, Manduca P.
    J Bone Miner Res; 2000 Nov; 15(11):2154-68. PubMed ID: 11092396
    [Abstract] [Full Text] [Related]

  • 9. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA, Jiang Z, Klingman NV, Pfahnl CL, Abouhamze ZS, Frase CD, Schultz GS, Ozaki CK.
    J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
    [Abstract] [Full Text] [Related]

  • 10. Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.
    Shek FW, Benyon RC, Walker FM, McCrudden PR, Pender SL, Williams EJ, Johnson PA, Johnson CD, Bateman AC, Fine DR, Iredale JP.
    Am J Pathol; 2002 May; 160(5):1787-98. PubMed ID: 12000730
    [Abstract] [Full Text] [Related]

  • 11. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL, Catanzaro DF, Supino PG, Gupta A, Carter J, Herrold EM, Dumlao TF, Borer JS.
    Cardiology; 2009 May; 113(3):161-8. PubMed ID: 19129699
    [Abstract] [Full Text] [Related]

  • 12. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT, Li H, Dillon L, Bryant JW.
    Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
    [Abstract] [Full Text] [Related]

  • 13. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
    Lu J, Hao J, Du H, Xiao B, Li Y, Yang X, Cui W.
    Cell Physiol Biochem; 2016 May; 39(1):47-60. PubMed ID: 27322513
    [Abstract] [Full Text] [Related]

  • 14. The expression and localization of selected matrix metalloproteinases (MMP-2, -7 and -9) and their tissue inhibitors (TIMP-2 and -3) in follicular cysts of sows.
    Grzesiak M, Kaminska K, Knapczyk-Stwora K, Hrabia A.
    Theriogenology; 2022 Jun; 185():109-120. PubMed ID: 35395587
    [Abstract] [Full Text] [Related]

  • 15. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang Y, Urbanski SJ.
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms.
    Elmore JR, Keister BF, Franklin DP, Youkey JR, Carey DJ.
    Ann Vasc Surg; 1998 May; 12(3):221-8. PubMed ID: 9588507
    [Abstract] [Full Text] [Related]

  • 18. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
    Hu J, Zhang X, Nothnick WB, Spencer TE.
    Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein.
    George SJ, Johnson JL, Angelini GD, Jeremy JY.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2500-6. PubMed ID: 9409220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.